Cargando…
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
INTRODUCTION: Uptake of oral pre-exposure prophylaxis (PrEP) remains low. The objective of this analysis was to estimate the potential market size in priority sub-Saharan African countries for a 28-day dual prevention pill (DPP) regimen containing the active pharmaceutical ingredients in oral PrEP a...
Autores principales: | Begg, Lorna, Brodsky, Rebecca, Friedland, Barbara, Mathur, Sanyukta, Sailer, Jim, Creasy, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292580/ https://www.ncbi.nlm.nih.gov/pubmed/32737137 http://dx.doi.org/10.1136/bmjsrh-2020-200662 |
Ejemplares similares
-
Patterns of Pre-exposure Prophylaxis (PrEP) Use in a Population Accessing PrEP in Jackson, Mississippi
por: Chase, Erin, et al.
Publicado: (2022) -
Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial
por: Corneli, Amy, et al.
Publicado: (2015) -
Perceptions, motivations, and beliefs about HIV risk and pre-exposure prophylaxis (PrEP) among participants in a nurse-led PrEP service (PrEP-RN)
por: Orser, Lauren, et al.
Publicado: (2022) -
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users
por: Smith, Dawn K., et al.
Publicado: (2013) -
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
por: Nozza, Silvia, et al.
Publicado: (2022)